Biotech



Biotech Recent News

Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Trial Data
Fed Agency Grants $14M To Gilgamesh For Cardiac-Safe Ibogaine Analog Targeting Opioid Use Disorder
Newly Diagnosed Cervical Cancer Patients - Merck's Blockbuster Drug Keytruda Plus Chemoradiotherapy Improves Overall Survival
Bristol Myers' Breyanzi Scores Second FDA Approval For Blood Cancers Therapy
FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer
Gilead's Aggressive Push Beyond HIV Treatments - Plans To Increase Cancer-Focused CAR-T Treatment Production
FDA Conditionally Approves Madrigal Pharmaceuticals' Resmetirom As First Treatment For Fatty Liver Disease With Scarring
What's Going On With Cancer Focused-Geron Stock On Friday?
Geron Stock Is Soaring After Hours: What's Going On?
Grifols Gets Downgraded: Fitch, S&P Flag Cash Flow Concerns At Pharma Company
Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall
Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits